glp 1 agonists reduce inflammation Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits Targeting GLP-1, GIP & GCG
Description
showed that the activation of GLP-1R by liraglutide led to an anti-tumor effect on human pancreatic cancer via the inhibition of the PI3K/AKT pathway (224)
If manufacturers are able to develop orals that rival the clinical profile of injectables, the market could be flipped on its head
The future will usher in multiple new ways of delivering GLP-1 medicines, and activating GLP-1R signaling pathways, promising improved efficacy/convenience
Biochem Pharmacol
A systematic review of acute pancreatitis as an adverse event of type 2 diabetes drugs: from hard facts to a balanced position
